Zentalis Pharmaceuticals (ZNTL) Insider Trading & Ownership → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free zntl Stock Alerts $12.57 -0.43 (-3.31%) (As of 04/23/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Zentalis Pharmaceuticals (NASDAQ:ZNTL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.10%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$108.08 MNumber OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$3.61 M Get ZNTL Insider Trade Alerts Want to know when executives and insiders are buying or selling Zentalis Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ZNTL Insider Buying and Selling by Quarter Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Zentalis Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/12/2024Cam GallagherPresidentSell1,173$11.44$13,419.12 2/12/2024Melissa B EpperlyCFOSell2,573$11.44$29,435.12 11/13/2023Kimberly BlackwellCEOBuy5,000$10.29$51,450.00 11/10/2023David Michael JohnsonDirectorBuy17,000$9.88$167,960.00 10/4/2023Carrie BrownsteinInsiderSell10,628$19.50$207,246.00 10/4/2023Melissa B EpperlyCFOSell5,482$19.50$106,899.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 9/11/2023Jan SkvarkaDirectorSell5,000$25.05$125,250.00 6/20/2023Matrix Capital Management CompMajor ShareholderBuy4,760,000$22.66$107,861,600.00 5/31/2023Cam GallagherPresidentSell27,768$26.27$729,465.36 5/26/2023Kevin D BunkerInsiderSell80,000$30.02$2,401,600.00 (Data available from 1/1/2013 forward) ZNTL Insider Trading Activity - Frequently Asked Questions Who is on Zentalis Pharmaceuticals's Insider Roster? The list of insiders at Zentalis Pharmaceuticals includes Alexis Pinto, Anthony Y Sun, Cam Gallagher, Carrie Brownstein, David Michael Johnson, Dimitris Voliotis, Jan Skvarka, Kevin D Bunker, Kimberly Blackwell, Matrix Capital Management Comp, and Melissa B Epperly. Learn more on insiders at ZNTL. What percentage of Zentalis Pharmaceuticals stock is owned by insiders? 6.10% of Zentalis Pharmaceuticals stock is owned by insiders. Learn more on ZNTL's insider holdings. Which Zentalis Pharmaceuticals insiders have been buying company stock? The following insiders have purchased ZNTL shares in the last 24 months: David Michael Johnson ($167,960.00), Kimberly Blackwell ($51,450.00), and Matrix Capital Management Comp ($107,861,600.00). How much insider buying is happening at Zentalis Pharmaceuticals? Insiders have purchased a total of 4,782,000 ZNTL shares in the last 24 months for a total of $108,081,010.00 bought. Which Zentalis Pharmaceuticals insiders have been selling company stock? The following insiders have sold ZNTL shares in the last 24 months: Cam Gallagher ($2,954,448.92), Carrie Brownstein ($207,246.00), Jan Skvarka ($125,250.00), Kevin D Bunker ($3,432,423.14), and Melissa B Epperly ($189,916.20). How much insider selling is happening at Zentalis Pharmaceuticals? Insiders have sold a total of 266,597 Zentalis Pharmaceuticals shares in the last 24 months for a total of $6,909,284.26 sold. More Insider Trading Tools from MarketBeat Related Companies: INVA Insider Trading SAVA Insider Trading SAGE Insider Trading SPRY Insider Trading ETNB Insider Trading ARQT Insider Trading OPK Insider Trading CYRX Insider Trading ARCT Insider Trading PLRX Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1Michael Burry Picked a Winner With GEN Restaurant Group This page (NASDAQ:ZNTL) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zentalis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
